We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App

Single Blood Draw to Detect Immune Cells Present Months before Flu Infection Can Predict Symptoms

By LabMedica International staff writers
Posted on 31 Aug 2023
Print article
Image: Immune cells present long before infection predict flu symptoms (Photo courtesy of Shutterstock.com)
Image: Immune cells present long before infection predict flu symptoms (Photo courtesy of Shutterstock.com)

For decades, if not centuries, scientists have struggled to solve the mystery of why certain individuals fall ill to infections while others remain unaffected. In an impressive development, researchers have now succeeded in measuring several immune parameters from a single blood sample and establishing correlations between these parameters and the likelihood of infection symptoms.

A dedicated team of scientists from St. Jude Children’s Research Hospital (Memphis, TN, USA) found that immune cells present in individuals prior to influenza (flu) infection can offer a more accurate prediction of symptom development compared to prevailing methods, which mainly depend on antibody levels. This study discovered specific immune cells linked with greater protection and others associated with higher vulnerability to symptom manifestation following contraction of the virus. The team found that possessing a functionally diverse set of immune cells corresponded to greater protection from flu symptoms. The researchers arrived at this conclusion after making a comparison of immune cell profiles in the blood of patients who experienced flu symptoms versus those who remained asymptomatic or uninfected.

Blood samples taken up to six months before the onset of the flu season revealed very different sets of immune cells in the two groups. Those devoid of symptoms displayed not only a more diverse set of immune cells but also cells that contributed to an influenza-specific long-term response, often termed the memory response. Conversely, patients exhibiting symptoms exhibited a more homogenous set of inflammatory immune cells, known for their involvement in a nonspecific, functionally constrained, and short-term response. Interestingly, the study showed that individuals who were vaccinated against the flu generally exhibited a surplus of protective anti-flu immune cells, enhancing their odds of evading symptoms. A rare subset of unvaccinated individuals who remained symptom-free seemed to possess immune cells mirroring the functions of protective cells seen in the vaccinated group. This insight could explain why certain people, even without vaccination, experience milder flu effects than others. Nonetheless, it underscores that vaccination offers the best defense against symptoms.

This breakthrough in identifying immune cell types related to susceptibility or resistance to the flu holds promise for improving prediction of influenza risk. Traditionally, clinicians and vaccine developers predicted flu susceptibility by examining anti-flu antibodies in the bloodstream. These antibodies, produced by specialized immune cells known as B-cells, hamper a virus's ability to infect cells. The study underscores that the presence of a diverse set of immune cells, particularly a high proportion of helper T cells (which play a role in long-term immune responses by "assisting" B cells), was better at predicting protection than relying solely on the analysis of antibodies. Moreover, the timing factor was quite unexpected. Even when blood samples were taken up to six months before flu exposure, they yielded strong predictive insights, thereby opening up new avenues for public health strategies.

“We were surprised that just by identifying the particular cellular populations and combing it with the serological antibody data, we could make such robust predictions,” said senior and co-corresponding author Paul Thomas, Ph.D., St. Jude Department of Immunology. “We may have the tools to understand susceptibility to infection already in our hands. We can only do it in the lab now, but it’s surprising and potentially exciting that, someday, we may get to a point where we can easily identify at-risk people and provide targeted support.”

“The exciting thing is that we could identify a subset of people at the beginning of the flu season that may be more likely to get symptomatic influenza,” said co-corresponding author Richard Webby, Ph.D., St. Jude Department of Host-Microbe Interactions. “We could predict who may be at risk well before the virus is even in the population. I don’t think we’ve really been in a position to even think about that before — this could open up new opportunities to prevent flu-based morbidity.”

Related Links:
St. Jude Children’s Research Hospital 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article


Molecular Diagnostics

view channel
Image: Prostate cancer cell image taken using a scanning electron microscope (Photo courtesy of LRI EM Unit)

New Discoveries of Prostate Cancer Evolution Pave Way for Genetic Test

Prostate cancer ranks as one of the most common cancers affecting men, and while it accounts for a significant number of male cancer fatalities, many men live with it rather than die from it.... Read more


view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more


view channel
Image: The photoacoustic spectral response sensing instrument is based on low-cost laser diodes (Photo courtesy of Khan et al., doi 10.1117/1.JBO.29.1.017002)

Compact Photoacoustic Sensing Instrument Enhances Biomedical Tissue Diagnosis

The pursuit of precise and efficient diagnostic methods is a top priority in the constantly evolving field of biomedical sciences. A promising development in this area is the photoacoustic (PA) technique.... Read more


view channel
Image: The companies will develop genetic testing systems based on capillary electrophoresis sequencers (Photo courtesy of 123RF)

Sysmex and Hitachi Collaborate on Development of New Genetic Testing Systems

Sysmex Corporation (Kobe, Japan) and Hitachi High-Tech Corporation (Tokyo, Japan) have entered into a collaboration for the development of genetic testing systems using capillary electrophoresis sequencers... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.